4/A

PRIMARY DOCUMENT

Company: HERON THERAPEUTICS, INC. /DE/
Filed: April 16, 2013
Period of Report: January 1, 2013
Accession Number: 0001426812-13-000005

View Document ↗ View on SEC.gov ↗